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Summary
Osmotic gradients across organelle and plasmamembranes
modulate the rates of membrane fission and fusion; suffi-
ciently large gradients can cause membrane rupture [1–6].
Hypotonic gradients applied to living yeast cells trigger
prompt (within seconds) swelling and fusion of Saccharo-
myces cerevisiae vacuoles, whereas hypertonic gradients
cause vacuoles to fragment on a slower time scale [7–11].
Here, we analyze the influence of osmotic strength on homo-
typic fusion of isolated yeast vacuoles. Consistent with pre-
viously reported in vivo results, we find that decreases in
osmolyte concentration increase the rate and extent of vac-
uole fusion in vitro, whereas increases in osmolyte concen-
tration prevent fusion. Unexpectedly, our results reveal that
osmolytes regulate fusion by inhibiting early Rab-dependent
docking or predocking events, not late events. Our experi-
ments reveal an organelle-autonomous pathway that may
control organelle surface-to-volume ratio, size, and copy
number: Decreasing the osmolyte concentration in the cyto-
plasmic compartment accelerates Rab-mediated docking
and fusion. By altering the relationship between the organ-
elle surface and its enclosed volume, fusion in turn reduces
the risk of membrane rupture.
Results
Organelle-Autonomous Regulation of Fusion
by Osmolyte Concentration
The yeast vacuole is, like the mammalian lysosome, the termi-
nal compartment of the endocytic pathway. Our cell-free
fusion system (Figure S1, available online) places purified
yeast vacuoles in a standard reaction buffer containing phys-
iological salts, 200 mM sorbitol, and ATP. Decreasing the
sorbitol concentration in the buffer increased the extent
(Figure 1A) and rate (Figure 1B) of fusion. Conversely, increas-
ing the sorbitol concentration decreased the extent and rate of
fusion and lengthened the lag time prior to fusion (Figure 1B).
Quantitative morphometry (Figure 1C) of fusion reactions
corroborated the results from content-mixing assays. These
in vitro results closely mirror observations of living cells [7–11].
The inhibitory effect of sorbitol is due to osmotic strength
rather than sorbitol’s specific physical or chemical properties.
Replacement of sorbitol with other small polar osmolytes, in-
cluding trehalose, glycerol, and sucrose (Figure S2A; unpub-
lished data), yielded results comparable to sorbitol. Glycerol
and trehalose are present at up to several percent (wt/vol) in
living yeast cells [12], indicating that they are not intrinsic
*Correspondence: merza@u.washington.eduinhibitors of membrane traffic. Dissolved solutes alter viscos-
ity and, through excluded-volume and hydration effects, the
chemical activity of water [13, 14]. A 15% solution of dex-
tran-5 is more viscous than a 15% solution of sorbitol but
has less than one-tenth as much osmotic strength; it slightly
stimulated fusion (Figure S2A). Thus, viscosity per se does
not prevent fusion. The results obtained with dextran-5 and
bovine serum albumin (Figure S2A) further indicate that
excluded-volume effects [13, 14] cannot explain inhibition by
sorbitol. Excluded-volume and hydration effects also shift
the ionic optima of many enzymatic reactions. Fusion is
most efficient atw125 mM KCl; this sharp ionic optimum did
not shift appreciably as the sorbitol concentration was varied
(Figure S2B). Thus, small polar solutes decrease the rate of fu-
sion by increasing osmotic strength. This effect is organelle
autonomous, requiring neither cytosol nor an intact plasma
membrane.
Osmotic Control of an Early Docking or Predocking
Subreaction
To map the osmotic effect to specific subreactions of fusion
(Figure S1), we performed kinetic studies with stage-specific
inhibitors (Figure 2A). A master fusion reaction was initiated.
At intervals, reaction aliquots were transferred to tubes
containing the specified treatments, incubated further, and
assayed for fusion. This approach tracks loss of susceptibility
to each treatment, i.e., the kinetics of completion of each sub-
reaction. Treatments that modulate only early subreactions
exhibit kinetics shifted left of the anti-Vam3 (docking) curve.
Treatments that modulate later subreactions map between
the anti-Vam3 and ‘‘ice’’ (content-mixing) curves. Unexpect-
edly, 1.4 M sorbitol inhibited fusion at early but not late time
points (Figure 2A). After 20 min, fusion was less than 90% re-
sistant to sorbitol addition, even though docking (anti-Vam3
curve) was less than 80% complete and content mixing (ice
curve) was onlyw30% complete. Lowering sorbitol to 100 mM
yielded identical kinetics: Fusion was accelerated at early
times but not late times.
Because the osmotic effect mapped to early docking, we
hypothesized that osmolytes modulate the kinetics of early-
or intermediate-stage subreactions. To test this hypothesis,
we assayed subreaction kinetics at three sorbitol concentra-
tions (Figure 2B). The earliest subreaction, Sec18- and
Sec17-mediated priming [15, 16], was not substantially influ-
enced by osmotic strength. Sec17 release from the mem-
brane, a biochemical correlate of priming, was also unaltered
(Figure 2B, inset). All subsequent stages of the reaction were
accelerated by reduced sorbitol concentration (100 mM versus
200 mM sorbitol) and slowed as sorbitol was added: tethering
and docking (rGdi1, an inhibitor of Rab GTPases); trans-
SNARE complex formation (anti-Vam3); and content mixing
(MARCKS effector-domain peptide [MED] [17]). Thus, osmo-
lytes regulate early docking and change the kinetics of Rab-
mediated subreactions. We next asked whether osmolytes
regulate tethering, operationally defined by the formation of
clusters of associated vacuoles [9, 18]. Consistent with the
kinetic and staging data, increasing buffer osmolarity strongly
decreased the efficiency of tethering (Figure 2C).
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1073Figure 1. Osmotic Control of Homotypic Vacuole Fusion
(A) In vitro homotypic vacuole fusion at the indicated concentrations of sorbitol was measured after a 90 min incubation. On the horizontal axis, measured
buffer osmolality is shown for reaction buffers containing the indicated concentrations of sorbitol. nR 4 for each point.
(B) Kinetics of fusion in hypotonic (100 mM), standard (200 mM), and hypertonic (600 mM sorbitol) conditions. n R 4 for each point; bars indicate
SEM.
(C) Vacuole diameter increases with fusion. Fusion increases both membrane area and volume, and hence the size of the vacuoles in the population. To
crosscheck the results obtained in content-mixing assays, we measured vacuole diameter at the end of 70 min fusion reactions containing the indicated
concentrations of sorbitol. The morphometric data are plotted in rank order in cumulative probability histograms, with the median vacuole diameter (50th
percentile) for each treatment indicated. We measured 500–1000 vacuoles from at least two experiments for each condition. The inset shows examples
of morphology of FM4-64-stained vacuoles after 70 min incubation with ATP. The scale bar represents 2.5 mm.Osmolytes Functionally Destabilize Ypt7:GTP
and the HOPS Complex
To further evaluate the molecular basis of the link between os-
motic strength and fusion, we measured dosage sensitivities
for several fusion inhibitors at four sorbitol concentrations
(Figure 3 and Figure S3). Osmolyte did not systematically
change the IC50 (50% inhibitory concentration) for affinity-puri-
fied antibodies raised against the priming factor Sec17 (Figures
S3A and S3C) or against the SNARE Vam3 (Figures 3A and 3C).
Unaltered IC50 values were also obtained for MED peptide [17],
a late-stage inhibitor of fusionthatchelatesacidicphospholipids
(Figure S3B). In contrast, dose-response relationships for two
Rab-specific inhibitors, the Rab-chelating chaperone rGdi1
and the GTPase activating protein (GAP) rGyp1TBC, were closely
linked to osmotic strength. IC50 values for rGdi1 and rGyp1TBC
increased by nearly an order of magnitude as osmolyte was de-
creased (Figure 3C; compare Figure 3A to Figure 3B). Consistent
with this result, in vivo overproduction of a second Ypt7 GAP,
Gyp7, caused superinhibition of vacuole fusion by osmolyte,
both in intact cells and in cell-free assays (unpublished data).
Thus, osmolytes inhibit Rab-regulated subreactions of fusion.
The Ypt7 effector complex HOPS is anchored to the mem-
brane by active Ypt7:GTP, so membrane association of HOPS
provides a functional proxy for Ypt7 activation [19, 20]. Differen-
tial centrifugation experiments revealed that HOPS subunits
were stabilized on membranes at low osmotic strength but
dissociated into the supernatant as osmotic strength was in-
creased (Figure 4A). Additional experiments with the Rab
chaperone rGdi and experiments with the poorly hydrolyzable
GTP analog GTPgS (which stabilizes activated Ypt7) further
support this interpretation (unpublished data). Taken together,
the data indicate that osmolytes functionally and biochemically
destabilize Ypt7:GTP and its HOPS effector complex.
Rab Hyperactivation or Bypass Partially Reverses
Osmotic Effects
We asked whether treatments that increase the quantity of
active Rab GTPase or attenuate the Rab requirement couldrestore fusion at elevated osmotic strength. First, we exploited
our previous finding that the recombinant SNARE rVam7 by-
passes the priming requirement for ATP [21, 22]. rVam7 also
reduces the Rab requirement and stabilizes HOPS on the vac-
uole membrane [21–24]. At elevated sorbitol concentrations,
rVam7 restored fusion to approximately half the level observed
under the standard condition (Figure 4B, top). At lower sorbitol
concentrations (100 mM), rVam7 slightly suppressed fusion.
This effect might result from SNARE-mediated lysis [24].
Second, we tested whether osmolyte-mediated inhibition is
attenuated when there is more active Rab on the vacuole
membrane. Gyp7 is the major Ypt7 GAP in vivo, and vacuoles
purified from gyp7D cells have elevated levels of both
Ypt7:GTP and HOPS (unpublished data). When fusion of vac-
uoles from gyp7D cells was measured at different concentra-
tions of osmolyte, the effect of osmolyte was attenuated, as
with rVam7 addition (Figure 4B, middle). Moreover, addition
of rVam7 to vacuoles isolated from gyp7D cells had an additive
effect, resulting in fusion at elevated osmotic strength that
approached the standard condition (data not shown).
Third, we exploited the finding that removal of the vacuolar
casein kinase I Yck3 dramatically reduces the requirement
for Ypt7:GTP both in vitro [11] and in vivo (unpublished data).
Vacuoles isolated from yck3Dmutant cells (Figure 4B, bottom),
like vacuoles from gyp7D mutants, fused more robustly than
vacuoles from wild-type cells as the osmolyte concentration
increased. Hence, the inhibitory effect of osmotic strength is
attenuated by three independent manipulations that either
stabilize the activated Rab or decrease the Rab requirement.
Discussion
Osmoregulation of docking and fusion is widespread, but the
mechanisms of osmotic sensing and the molecular targets of
this regulation are unknown. In Paramecium, membrane ten-
sion generated by osmotic pressure was hypothesized to
trigger cycles of vacuole exocytosis for locomotion [2]. In
mammalian cells, the rapid coalescence of intracellular
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(A) Kinetic mapping of osmotic effect. At the times indicated, aliquots of standard vacuole fusion reactions (200 mM sorbitol) were shifted to a final sorbitol
concentration of 100, 200, or 1400 mM, as indicated, and incubated for a total of 90 min. Data are normalized to the values obtained with reactions diluted
in isotonic (200 mM sorbitol) buffer. Kinetics are also shown for inhibitors of docking (Vam3 antibody, 35 nM) and fusion (ice) at standard 200 mM sorbitol.
nR 4 independent experiments.
(B) Osmotic control of docking kinetics. At the indicated times, subreaction inhibitors were added to reactions containing 100, 200, or 600 mM sorbitol
throughout the incubation. Fusion inhibitors include the following (from early- to late-stage inhibition): 322 nM Sec17 antibody, 14 mM rGdi1, and 35 nM
Vam3 antibody. The data are normalized to fusion values obtained in control samples, to which fusion buffer was added in place of inhibitor at the indicated
times (gray lines). The inset shows vacuoles that were incubated with or without ATP for 10 min in the presence of 100, 200, or 600 mM sorbitol and then
sedimented. The amount of Sec17 released from the membrane pellet was determined by western blot analysis with one-sixth of the supernatant from each
fusion reaction. nR 4 independent experiments.
(C) Osmotic inhibition of tethering. Images show FM4-64-stained vacuoles after 30 min of incubation with or without ATP in the presence of 100, 200,
600, or 1000 mM sorbitol. The scale bar represents 6 mm. Vacuole clusters were scored under each condition, and data are presented as a percent-
age of the total. A cluster refers to a single group of vacuoles. At least 200 clusters were counted for each condition. Error bars denote means 6
SEM.organelles, triggered by hypo-osmotic gradients, was re-
ported almost a century ago [1]. There is a general correlation
between low osmolarity in the cytoplasm or high osmolarity in
an extracytoplasmic compartment and fusion [3–6]. For exam-
ple, exocytosis is triggered by extracytoplasmic osmolytes,
such as sucrose [5, 6], and inhibited by osmolyte in the cyto-
plasmic compartment [3]. In this study, we found that osmotic
shifts influence fusion when applied during early docking but
are without effect during later subreactions. Taken together,
our experiments show that osmolytes can control an organ-
elle’s docking machinery in an organelle-autonomous manner,
and they are fully consistent with earlier in vivo observations
[7–11].
In principle, osmosensors could operate directly, e.g., by
detecting changes in hydration, or indirectly, by sensing
changes in membrane properties as osmotic gradients cause
water and ionic species to flow across a membrane. Dai et al.
recorded spontaneous lateral tension changes of w40 mN/m
during exocytosis and endocytosis in rat basophilic leukemiacells [4]. Both organelle-organelle and exocytotic fusion
events introduce slack into the product membrane, increasing
the surface-to-volume ratio of the organelle or cell. This in turn
increases the capacity for inward water movement without ly-
sis. Thus, the ability of the docking machinery to respond to
osmolytes may serve to prevent membrane tension from rising
to perilous (lytic) levels during osmotic stress. Lytic tension for
lysosomes and vacuoles may be lower than for other mem-
branes because lysis might be accelerated by lipases and
other hydrolases that reside within the organelle lumen. Hypo-
osmotic stress can rupture lysosomes, to catastrophic effect
[25], and experiments by Starai and coworkers [24] demon-
strated that SNARE overabundance promotes membrane rup-
ture, indicating that even normal membrane traffic functions
are not without hazards. Coupling the activity of the docking
machinery to cytoplasmic osmolyte concentration or to trans-
membrane osmotic gradients may be central to maintenance
of organelle surface-to-volume relationships and membrane
integrity.
Osmotic Control of Membrane Docking
1075Figure 3. Osmolytes Enhance Sensitivity of Fusion to Rab Inhibitors
(A and B) Homotypic vacuole fusion was measured after vacuoles were incubated with ATP for 90 min in the presence of 100, 200, 600, or 1000 mM sorbitol
and increasing concentrations of (A) Vam3 antibody or (B) rGdi1. Sigmoidal dose-response curves were fit to the data sets.
(C) IC50 values were extracted from the fits shown in (A) and (B) and from similar curves for other inhibitors (see Figures S3A–S3C). Bars span 95% confidence
intervals; n R 4 for all experiments shown. Dose response for additional inhibitors and an alternative presentation of the IC50 values is presented in
Figure S3D.Experimental Procedures
Yeast Strains
For fusion assays, we used complimentary strain pairs of either BJ3505
(MATa pep4::HIS3 prb1-1.6R his3–200 lys2–801 trp1101 (gal3) ura3–52
gal2 can1) and DKY6281 (MATa leu2–3 leu 2–112 ura3–52 his3-200 trp1-
901 lys2–801) or BY4742 pho8D and BY4742 pep4D (MAT a ura3D leu2D
his3D lys2D pep4D::neo; Invitrogen, Carlsbad, CA). BJ3505 gyp7D::URA3
and DKY6281 gyp7D::URA3 were gifts from Dr. Dieter Gallwitz (Max Planck
Institute of Biophysical Chemistry, Go¨ttingen, Germany). BY4742 yck3D
pho8D (= AMY809) and BY4742 yck3D pep4D (= AMY807) were constructed
by crossing and sporulating BY4741 yck3D (MATa his3D leu2D met15D
ura3D yck3D::neo; Invitrogen) against BY4742 pep4D::neo or BY4742
pho8D::neo. Genotypes of the resulting haploid strains were confirmed by
PCR and DNA sequencing.
Reagents
All biochemical reagents were purchased from Sigma-Aldrich (St. Louis, MI)
or Invitrogen, except as indicated, and were of biotechnology grade orbetter. The endoglucanase fraction of Zymolyase 20T (Seikigaku Kogyo,
Tokyo, Japan) was purified by cation-exchange chromatography before
use in vacuole isolation. Purified proteins used include recombinant Vam7
(rVam7 [21]; unpublished data); recombinant Gdi1 (rGdi1) purified from
bacterial cells with a CBP-intein fusion system provided by V. Starai and
W. Wickner; recombinant catalytic domain of Rab-GAP Gyp1 (rGyp1TBC)
[19]; synthetic MARCKS Effector Domain peptide [17]; and recombinant
protease inhibitor Pbi2. Rabbit polyclonal sera raised against Vps41,
Vps33, Vps18, Vps11, Ypt7, Sec17, and Vam3 were gifts from W. Wickner
(Dartmouth College, Hanover, NH), and were affinity purified and in some
cases crossadsorbed against cell lysates from corresponding yeast dele-
tion mutants to eliminate crossreactivity. The protein reagents used in fu-
sion assays were prepared in 10 mM Pipes-KOH (pH 6.8) 200 mM sorbitol
(PS) or were exchanged into this buffer by dialysis or size-exclusion chro-
matography.
Fusion
Vacuoles were purified as described [26]. Isolated vacuoles (6 mg) were
incubated for 90 min at 27C in standard reaction buffer: PS bufferFigure 4. Interplay between Osmotic Strength
and Docking Factors
(A) Osmolyte-triggered HOPS dissociation from
the vacuole. Vacuoles were incubated with or
without ATP for 70 min in the presence of 100,
200, 600, or 1000 mM sorbitol and then sedi-
mented. Membrane association of 4 HOPS com-
ponents (Vps41, Vps33, Vps18, and Vps11), a vac-
uole Qa-SNARE (Vam3), and the vacuole Rab
GTPase (Ypt7) was assessed by western blot
with one-third of the total isolated supernatent
(S) and one-tenth (0.6 mg vacuole protein) of the
pellet (P). Phospho-Vps41 (*) was observed ex-
clusively in the presence of ATP, as reported [11].
(B) Rab activation or partial Rab bypass attenu-
ates inhibition by osmolyte. Top: Vacuoles were
incubated for 90 min with ATP at increasing sor-
bitol concentrations in the presence and absence
of recombinant Qc-SNARE rVam7, which reduces
the Ypt7 requirement in fusion [21, 22]. Middle
and bottom: Vacuoles were purified from yeast
strains containing or lacking Gyp7 (middle),
which, when absent, stabilizes membrane asso-
ciation of Ypt7 and components of HOPS (unpublished data) or the vacuolar casein kinase I Yck3 (bottom), which, when absent, stabilizes HOPS on the
membrane [11]. Fusion data were normalized to either the mean rate of fusion under standard conditions (ATP only, 200 mM sorbitol; top) or conditions
where maximum fusion values were observed (100 mM sorbitol; middle, bottom). nR 4 for each point; error bars denote means6 95% confidence intervals.
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1076supplemented with salts (5 mM MgCl2, 125 mM KCl), CoA (10 mM), and Pbi2
(with or without ATP-regenerating system [1 mM ATP, 0.1 mg/ml creatine
kinase, 40 mM creatine phosphate]). Vacuoles were always added last to
a premixed reaction cocktail, unless otherwise specified. Bypass fusion
was initiated with recombinant Vam7 (100 nM, except as indicated).
Osmotic gradients were imposed by reducing or adding sorbitol to the stan-
dard fusion reaction buffer (200 mM sorbitol). Like sorbitol, KCl concentra-
tions were adjusted without compensatory equiosmolar changes in other
buffer constituents. The solution’s total osmolalities (Figure 1A and Table
S1) were measured with a Vapro 5520 vapor-pressure osmometer (Wescor,
Logan, UT). As indicated, reactions also contained rGdi1, rGyp1TBC, Sec17
antibody, Vam3 antibody, rGyp1TBC, MED, or GTPgS. Total volume of each
fusion reaction was 30 ml. Fusion reactions were prepared with BY4742
pho8D (or DKY6128; alkaline phosphatase deficient) and pep4D (or
BJ3505; protease deficient) vacuoles (3 mg each), with or without genomic
deletion of YCK3 (yck3D) or GYP7 (gyp7D). Homotypic vacuole fusion was
measured with a biochemical complementation assay ([26]; see [18] for
quantitative characterization of the reporter system). Fusion (content mix-
ing) was quantified by measuring the ALP-catalyzed evolution of p-nitro-
phenolate at 400 nm. Signals were then subtracted from a background
control reaction either lacking ATP or incubated on ice; the signal-to-back-
ground ratio under our standard conditions routinely exceeds 25:1. Results
are reported relative to signals obtained under standard fusion conditions
(200 mM sorbitol with ATP), unless otherwise indicated. Under standard
conditions, the mean extent of fusion was 3.5 (n = 98) fusion units as defined
previously, corresponding to approximately two rounds of fusion [18, 26]. In
addition, we verified that sorbitol does not alter the efficiency of ALP activa-
tion in assays with vacuole lysates (data not shown) [18]. Vacuole membrane
release of Sec17, Ypt7, and HOPS components was assessed with fusion
reactions containing only protease-deficient vacuoles (6 mg pep4D or
BJ3505). After incubation at 27C for 10 min, 40 min, or 70 min, fusion reac-
tions were immediately sedimented by centrifugation at 20,0003 g for 5 min
at 4C. Pellet and supernatent fractions were fractionated by SDS-PAGE
and analyzed by immunoblotting.
Microscopy
To examine vacuole morphology in vitro, we incubated pep4D vacuoles for
times indicated (30 min or 70 min) at 27C in fusion reaction buffer contain-
ing 3.0 mM FM4-64. After incubation, reactions were placed on ice. Then 2 ml
of each reaction was mixed with 0.4% agarose, mounted on a chilled glass
coverslip, and immediately imaged. Vacuole diameters and contact-zone
lengths were measured from micrographs subjected to high-pass and
sharpening filters with Image/J v. 1.36b software (Wayne Rasband, National
Institutes of Health (NIH), Wachington, DC). Vacuole-clustering analysis was
performed as described [9] with minor modifications: No cytosol was added
to reactions, and KCl was not reduced to 40 mM. In brief, 5 mg of pep4D vac-
uoles were incubated at 27C for 30 min in reaction buffer containing MgCl2
(1.0 mM) and FM4-64 (3.0 mM) in the absence or presence of a lower than
conventional concentration of ATP-regenerating system (0.6 mM ATP).
Then 2 ml of the reaction was imaged as described above. Micrographs
were acquired with an Olympus IX71 light-microscope system outfitted
with an EMCCD (Andor iXon), ultrabright green- and blue-light-emitting di-
odes (>350 mW output) synchronized with the camera by custom electron-
ics, a PlanApoN 1.45 NA 603 objective lens, and AndorIq v. 6.0.3.62 soft-
ware (Andor Bioimaging, Nottingham, UK). Micrographs were processed
with Image/J v. 1.36b (J. Rasband, NIH, http://rsb.info.nih.gov/ij/) and
PhotoshopCS v. 8.0 (Adobe Systems) software.
Data Analysis
Where applicable, data sets were fit to sigmoidal dose-response functions
with a nonlinear least-squares algorithm. log IC50 estimates were ex-
tracted from the sigmoidal fits with Prism v. 4.0c software (GraphPad,
San Diego, CA). Statistical comparisons were performed with two-tailed
Student’s t tests (paired or unpaired, as appropriate); significance was
assumed at the 5% level, after Dunn-Sidak compensation for repeated
comparisons.
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